Human Metapneumovirus (HMPV) is one of the viral respiratory pathogens that may cause symptoms almost as flu-like, such as a cough, fever, throat pain, runny nose, and wheezing. Though most infections are mild in nature, it tends to cause severe ones in some at-risk populations, such as infants, elderly adults, and others whose immune systems are compromised.
In this detailed blog, we will know the discovery, mode of transmission, symptoms, diagnosis, treatment, and prevention of HMPV and the new findings related to the virus.
History and Classification of HMPV
In the year 2001, a team of scientists detected HMPV in the Netherlands from the respiratory secretions of young children. It was classified as belonging to a family called Pneumoviridae, to which other respirator viruses other than RSV belong. The HMPV however is not quite the same because it has significant differences with those of RSV.
Since that time, scientists have discovered to be one among the major leading causes of a respiratory infection in children and the elderly plus immunocompetent patients. This is important information since the disease often takes the form of the common cold and hence may be confused with any other viral infection.
Transmission and Epidemiology of HMPV
HMPV is transmitted by droplet spread of the droplets from the infected when coughing, sneezing or talking, apart from this it can also spread through direct contact with contaminated surfaces and articles. Like most of the respiratory viruses, HMPV is mainly transmitted during the cold months.
This usually happens at the time of flu and RSV season. Its high transmission rates normally occur between winter and early spring but can be experienced throughout the year depending on some outbreaks.
Another characteristic peculiar to HMPV is its annual cyclic pattern which allows it to share the same transmission features as better known viruses such as the influenza virus.
Current findings from data reported by the Center for Disease Prevention and Control have shown an increase in respiratory conditions during the colder seasons, which to a great extent was due to HMPV.
Between December 16 and 22, 2024, 6.2% of positive respiratory illness tests were for HMPV, which led to increased hospitalizations in children under 14. Now, the virus is monitored closely, considering the potential spread in nearby countries.
Read our new blog: India vs Australia Test Series 2024
Symptoms and Clinical Manifestation of HMPV
HMPV infection may be linked to a broad range of symptoms, ranging from mild upper respiratory tract discomfort to severe lower respiratory tract disease. Such symptoms include but not limited to; upper respiratory symptoms: such as runny nose, sore throat, coughing, congestion, and sneezing.
Such symptoms are typically mild and might be as slight as symptoms seen in a case of common cold or minor case of flu.
Lower Respiratory Symptoms: In more severe cases, HMPV can cause bronchiolitis, pneumonia, or exacerbate asthma or COPD. Lower respiratory tract involvement is characterized by wheezing, dyspnea, and persistent cough.

Milder symptoms occur in immunocompetent adults but are more serious in children and the elderly. However, among some populations like infants, the elderly, and immunocompromised patients, HMPV infections may be severe and thus require medical intervention or even hospitalization.
Read more about: HMPV वायरस: लक्षण और उपचार के प्रभावी तरीके
HMPV diagnosis
Generally, the diagnosis of HMPV is done clinically through laboratory tests. For proper diagnosis, health care providers might need to do a physical examination and history with the patient in detail.
Still, the clinical presentation alone cannot be used as a diagnosis for HMPV infection because many symptoms are overlapping and similar to diseases such as the flu, RSV, or common cold.
Confirmation of an HMPV diagnosis would most appropriately be based on the PCR test in which the genetic material of the virus would be detected within samples of respiratory swabs, which may include a nasal swab or a throat swab. Further, serological tests will help in detection of antibodies which react against the virus and depict previous exposure or infection.
Treatment and management of HMPV
There is no specific antiviral drug to date that is used for the treatment of HMPV. Treatment involves symptomatic relief and supportive care. The following are the strategies in managing HMPV infection:
- Symptomatic Relief: Over-the-counter medications can be used to alleviate symptoms such as fever, congestion, and sore throat. The use of decongestants, antihistamines, and pain relievers reduces discomfort during the illness.
- Hydration: Hydration is very fundamental to the body whenever it is experiencing a fever or sweating, as this can prevent dehydration and allows the immune system to fight the infection process.
- Rest: Resting allows sufficient healing time for the immune system to respond to infections. Infected individuals with HMPV are advised to stay indoors, rest and give their immune system time to fight off the viruses.
In severe cases, especially in high-risk populations, hospitalization is required. Such patients in hospitals are managed for complications like pneumonia or bronchiolitis with supplemental oxygen therapy and intravenous fluids. In some cases, where the respiratory distress is pronounced, mechanical ventilation may be required.
Prevention of HMPV
Prevention of HMPV spread is not essentially different from how other respiratory viruses are prevented. Some of the major prevention methods include:
- Hand Hygiene: The most important preventive measure is hand washing with soap and water for at least 20 seconds. If there is no access to soap and water, hand sanitizers are available.
- Respiratory Etiquette: When coughing or sneezing, the nose and mouth must be covered by a tissue or the elbow so that the spread of respiratory droplets is avoided.
- Individuals with HMPV infections should avoid direct contact, especially with the immunocompromised, such as children, elderly, and patients suffering from immunodeficiency.
- Hygiene: It is believed that cleaning and disinfecting contact objects, including door handles, light switches, and remotes, may reduce the transmission of HMPV.

Since HMPV is seasonal, precautions are usually more pronounced in peak months. Public health measures are typically targeted at hygiene, proper respiratory etiquette, and staying home when ill to decrease the spread of the virus.
Recent Developments and Concerns
Public health officials grew alarmed by the growing number of cases due to HMPV infection, especially in China. In December 2024, there was a sudden upsurge in cases of respiratory infections wherein a good percentage of tests done were positive for HMPV.
This, according to the authorities, is not an unusual seasonal surge, but public health officials still appealed for the public to be vigilant and take precautions against the outbreak of the virus.
Neighboring countries have heightened their surveillance activities and readied their prepared responses when the time comes. The virus is still spreading; there is still much need to be prepared and vigilant in health systems for the hospitalization surge, especially in high-risk populations.
Conclusion
Human Metapneumovirus is a serious respiratory pathogen, presenting a spectrum of illness ranging from the mild cold-like symptoms to severe respiratory illness. Most of the cases are relatively mild and self-limiting, but susceptible individuals may present with severe complications.
No specific treatment for HMPV has been developed to date, and supportive care is the mainstay of management. Preventive measures like good hygiene, proper respiratory etiquette, and avoiding close proximity to affected individuals can reduce its spread.
Since the virus is seasonal in its pathology and sometimes causes outbreaks, there should be continuous education about the HMPV and appropriate protection measures for an individual and society. Continued research and surveillance can be helpful in managing HMPV better, thus improving outcomes for patients suffering from the disease.